Kevin Loewke

Kevin Loewke is the current head of data science at Alife. Prior to this, they were the co-founder and managing member of Dana Solutions, which was acquired by Curi Bio. Kevin was also the co-founder and CEO of Cellogy Inc.

Loewke has a background in AI for life sciences applications. Kevin has worked with over 20 clients in pharma/biotech, medical devices, and academia. Kevin has also conducted original research in collaboration with CDER at FDA, which was published and presented at scientific conferences.

Loewke is responsible for company strategy and growth, and technical implementation on a variety of projects involving deep learning for different data types (microscopy, electrophysiology, sensor data) across multiple applications (phenotypic drug discovery, toxicity testing, cell counting, automation, and more).

These colleagues work with Kevin Loewke in the Data Science department at their company. They are responsible for different areas of the company, but work together to ensure that the company runs smoothly and efficiently.